RecruitingNCT03450577

International Bifurcation Study

International Prospective Register on Treatment of Coronary Artery Bifurcation Lesions


Sponsor

Meshalkin Research Institute of Pathology of Circulation

Enrollment

5,000 participants

Start Date

Jan 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The IBS registry is an observational, multi-center, real-world registry of stenting in coronary bifurcation lesions that will collect information on procedures and outcomes from various participating centers. The aim of this registry is to investigate long-term clinical results and predictors of adverse outcomes after PCI for coronary bifurcation lesions among various participating centers.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria2

  • Age ≥ 18 years
  • Any type of bifurcation lesion in major epicardial artery

Exclusion Criteria1

  • Patient refused informed consent to participate in the registry

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPCI of bifurcation lesions

Different approaches for treatment of bifurcation coronary artery disease.


Locations(1)

Meshalkin National Research Center

Novosibirsk, Novosibirsk Oblast, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03450577


Related Trials